Peter T. Vedell

2.0k citations

22 papers · 852 indexed · 1 hit paper · h-index 12

Biological Psychiatry top 5%
Behavioral Neuroscience top 5%
- Stress Responses and Cortisol 2
Cancer Research
- Cancer Genomics and Diagnostics 7
Infectious Diseases
Aging
Pulmonary and Respiratory Medicine
- Prostate Cancer Treatment and Research 5
Molecular Biology
- Bioinformatics and Genomic Networks 3
- RNA modifications and cancer 2
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 2
Oncology
- Cancer Cells and Metastasis 2
Genetics
- Estrogen and related hormone effects 2

Co-authors: Gary A. Churchill Katherine D. Blizinsky Eva E. Redei Krishna R. Kalari Karunya K. Kandimalla Eva M. Carmona Porquera Sanjana Nair Jessica Wright
Cited by: Biological Psychiatry Behavioral Neuroscience Cancer Research
Journals: Journal of Clinical Oncology (2 papers)Bioinformatics (1 paper)Cancer Research (1 paper)
Partner nations: United States Canada China

In The Last Decade

Peter T. Vedell

22 papers receiving 838 citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Peter T. Vedell

Since Specialization

Citations

This map shows the geographic impact of Peter T. Vedell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter T. Vedell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter T. Vedell more than expected).

Fields of papers citing papers by Peter T. Vedell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter T. Vedell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter T. Vedell. The network helps show where Peter T. Vedell may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter T. Vedell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter T. Vedell Line = papers co-authored together Peter T. Vedell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors Breast Cancer Research ·Xiaojia Tang,Kevin J. Thompson,Krishna R. Kalari,Jason P. Sinnwell,Vera J. Suman,Peter T. Vedell,Sarah A. McLaughlin,Donald W. Northfelt,Alvaro Moreno Aspitia,Richard J. Gray,Jodi M. Carter,Richard M. Weinshilboum,Liewei Wang,Judy C. Boughey,Matthew P. Goetz	2023	2
2	Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment Molecular Cancer Research ·Hugues Sicotte,Krishna R. Kalari,Sisi Qin,Scott M. Dehm,Vipul Bhargava,Michael Gormley,Winston Tan,Jason P. Sinnwell,David W. Hillman,Ying Li,Peter T. Vedell,Rachel E. Carlson,Alan H. Bryce,Raphael E. Jimenez,Richard M. Weinshilboum,Manish Kohli,Liewei Wang	2022	9
3	Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX) npj Breast Cancer ·Yongxian Zhuang,Jordan Grainger,Peter T. Vedell,Jia Yu,Ann M. Moyer,Huanyao Gao,Xiao-Yang Fan,Sisi Qin,Duan Liu,Krishna R. Kalari,Matthew P. Goetz,Judy C. Boughey,Richard M. Weinshilboum,Liewei Wang	2021	7
4	COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategiesbreakdown → Molecular Pharmaceutics ·Vrishali S. Salian,Jessica Wright,Peter T. Vedell,Sanjana Nair,Chenxu Li,Mahathi Kandimalla,Xiaojia Tang,Eva M. Carmona Porquera,Krishna R. Kalari,Karunya K. Kandimalla	2021	184
5	Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer iScience ·Asha Nair,Xiaojia Tang,Kevin J. Thompson,Peter T. Vedell,Krishna R. Kalari,Subbaya Subramanian	2020	4
6	PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient JCO Clinical Cancer Informatics ·Krishna R. Kalari,Jason P. Sinnwell,Kevin J. Thompson,Xiaojia Tang,Erin E. Carlson,Jia Yu,Peter T. Vedell,James N. Ingle,Richard M. Weinshilboum,Judy C. Boughey,Liewei Wang,Matthew P. Goetz,Vera J. Suman	2018	11
7	TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer Clinical Pharmacology & Therapeutics ·Sisi Qin,Duan Liu,Manish Kohli,Liguo Wang,Peter T. Vedell,David W. Hillman,Nifang Niu,Jia Yu,Richard M. Weinshilboum,Liewei Wang	2017	29
8	Association of Wnt pathway activation with prechemotherapy abiraterone acetate resistance in metastatic castration-resistant prostate cancer (mCRPC) by genome-wide analysis of metastases. Journal of Clinical Oncology ·Manish Kohli,Liguo Wang,Scott M. Dehm,David W. Hillman,Hugues Sicotte,Michael Gormley,Vipul Bhargava,Deborah Ricci,Weimin Li,Winston Tan,Brian A. Costello,Henry C. Pitot,Roxana Dronca,Thai H. Ho,Alan H. Bryce,Zhenqing Ye,Peter T. Vedell,Poulami Barman,Rachel E. Carlson,Liewei Wang	2017	1
9	Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer BMJ Open ·Steven N. Hart,Marissa S. Ellingson,Kim Schahl,Peter T. Vedell,Rachel E. Carlson,Jason P. Sinnwell,Poulami Barman,Hugues Sicotte,Jeanette E. Eckel‐Passow,Liguo Wang,Krishna R. Kalari,Rui Qin,Teresa Kruisselbrink,Rafael E. Jiménez,Alan H. Bryce,Winston Tan,Richard Weinshilboum,Liewei Wang,Manish Kohli	2016	28
10	Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma Journal of Thoracic Oncology ·Jin Sung Jang,Xiaoke Wang,Peter T. Vedell,Ji Wen,Jinghui Zhang,David W. Ellison,Jared M. Evans,Sarah H. Johnson,Ping Yang,William R. Sukov,André M. Oliveira,George Vasmatzis,Zhifu Sun,Jin Jen,Eunhee S. Yi	2016	33
11	Measure transcript integrity using RNA-seq data BMC Bioinformatics ·Liguo Wang,Jinfu Nie,Hugues Sicotte,Ying Li,Jeanette E. Eckel‐Passow,Surendra Dasari,Peter T. Vedell,Poulami Barman,Liewei Wang,Richard Weinshiboum,Jin Jen,Haojie Huang,Manish Kohli,Jean‐Pierre Kocher	2016	144
12	PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data Bioinformatics ·Chen Wang,Jared M. Evans,Aditya Bhagwate,Naresh Prodduturi,Vivekananda Sarangi,Mridu Middha,Hugues Sicotte,Peter T. Vedell,Steven N. Hart,Gavin R. Oliver,Jean‐Pierre Kocher,Matthew J. Maurer,Anne J. Novak,Susan L. Slager,James R. Cerhan,Yan W. Asmann	2014	34
13	Global molecular changes in rat livers treated with RXR agonists: a comparison using transcriptomics and proteomics Pharmacology Research & Perspectives ·Peter T. Vedell,Reid Townsend,Ming You,James P. Malone,Clinton J. Grubbs,Kirby I. Bland,Donald D. Muccio,Venkatram R. Atigadda,Chen Yang,Katie Vignola,Ronald A. Lubet	2014	5
14	Concordant Effects of Aromatase Inhibitors on Gene Expression in ER+ Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes Cancer Prevention Research ·Yan Lü,Ming You,Zara Ghazoui,Pengyuan Liu,Peter T. Vedell,Weidong Wen,Ann M. Bode,Clinton J. Grubbs,Ronald A. Lubet	2013	10
15	Effects on Gene Expression in Rat Liver after Administration of RXR Agonists: UAB30, 4-Methyl-UAB30, and Targretin (Bexarotene) Molecular Pharmacology ·Peter T. Vedell,Yan Lü,Clinton J. Grubbs,Yuxin Yin,Hui Jiang,Kirby I. Bland,Donald D. Muccio,Dusica Cvetković,Ming You,Ronald A. Lubet	2013	28
16	Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression Translational Psychiatry ·Kathleen Pajer,B M Andrus,William Gardner,Andrea Lourie,Brandon Strange,John V. Campo,Jeffrey A. Bridge,Katherine D. Blizinsky,K Dennis,Peter T. Vedell,Gary A. Churchill,Eva E. Redei	2012	79
17	Transcriptomic analysis by RNA‐seq reveals AP‐1 pathway as key regulator that green tea may rely on to inhibit lung tumorigenesis Molecular Carcinogenesis ·Jing Pan,Qi Zhang,Donghai Xiong,Peter T. Vedell,Yan Yan,Hui Jiang,Peng Cui,Feng Ding,Jay W. Tichelaar,Yian Wang,Ronald A. Lubet,Ming You	2012	15
18	Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non–small cell lung carcinoma from Chinese patients Carcinogenesis ·Donghai Xiong,Guangming Li,Kezhen Li,Qinzi Xu,Zhongjie Pan,Feng Ding,Peter T. Vedell,Pengyuan Liu,Peng Cui,Xing Hua,Hui Jiang,Yuxin Yin,Ze Zhu,Xiaomian Li,Bin Zhang,Ding Ma,Yian Wang,Ming You	2012	49
19	Stochastic variation of transcript abundance in C57BL/6J mice BMC Genomics ·Peter T. Vedell,Karen L. Svenson,Gary A. Churchill	2011	22
20	Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models Molecular Psychiatry ·B M Andrus,Katherine D. Blizinsky,Peter T. Vedell,K Dennis,Pradeep K. Shukla,Daniel J. Schaffer,Jelena Radulović,Gary A. Churchill,Eva E. Redei	2010	155

About Peter T. Vedell

Peter T. Vedell is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Cancer Research, having authored 22 papers that have together received 852 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Prostate Cancer Treatment and Research (5 papers), Bioinformatics and Genomic Networks (3 papers), Stress Responses and Cortisol (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cancer Cells and Metastasis (2 papers), RNA modifications and cancer (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Biological Psychiatry (103 citations), Behavioral Neuroscience (121 citations) and Cancer Research (137 citations). Peter T. Vedell has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Gary A. Churchill, Katherine D. Blizinsky, Eva E. Redei, Krishna R. Kalari, Karunya K. Kandimalla, Eva M. Carmona Porquera, Sanjana Nair, Jessica Wright, Chenxu Li and Xiaojia Tang. Their work appears in journals such as Journal of Clinical Oncology, Bioinformatics and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact